Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Net Margin (2018 - 2026)

Health Catalyst filings provide 9 years of Net Margin readings, the most recent being 156.91% for Q1 2026.

  • On a quarterly basis, Net Margin fell 12702.0% to 156.91% in Q1 2026 year-over-year; TTM through Mar 2026 was 87.69%, a 6435.0% decrease, with the full-year FY2025 number at 57.2%, down 3453.0% from a year prior.
  • Net Margin hit 156.91% in Q1 2026 for Health Catalyst, down from 121.89% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 17.81% in Q2 2024 to a low of 156.91% in Q1 2026.
  • Median Net Margin over the past 5 years was 40.37% (2023), compared with a mean of 49.28%.
  • Biggest five-year swings in Net Margin: soared 3704bps in 2023 and later tumbled -12702bps in 2026.
  • Health Catalyst's Net Margin stood at 51.68% in 2022, then grew by 22bps to 40.37% in 2023, then soared by 36bps to 25.97% in 2024, then plummeted by -369bps to 121.89% in 2025, then dropped by -29bps to 156.91% in 2026.
  • The last three reported values for Net Margin were 156.91% (Q1 2026), 121.89% (Q4 2025), and 29.12% (Q3 2025) per Business Quant data.